Segment Information (Tables)

12 Months Ended

Dec. 31, 2021

Segment Reporting [Abstract]

Summary of Information by Reportable Segments

The following table presents information about the Company’s reportable segments for the years ended December 31, 2021, 2020 and 2019 (in thousands):

	Years Ended December 31,
	2021									2020									2019
(in thousands)	Sorrento Therapeutics			Scilex			Total			Sorrento Therapeutics			Scilex			Total				Sorrento Therapeutics			Scilex			Total
External revenues	$	24,358		$	28,546		$	52,904		$	13,655		$	26,331		$	39,986			$	10,399		$	21,033		$	31,432
Operating expenses		387,200			67,155			454,355			225,687			58,817			284,504				130,529			160,296			290,825
Operating (loss) income		(362,842	)		(38,609	)		(401,451	)		(212,032	)		(32,486	)		(244,518	)			(120,130	)		(139,263	)		(259,393	)
Unrestricted cash		32,178			4,487			36,665			51,475			4,989			56,464				12,176			10,345			22,521